| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |